News
BMS doubles down on BridgeBio alliance on SHP2 drugs
Phil Taylor
BridgeBio Pharma, Bristol-Myers Squibb, immuno-oncology, Oncology, Opdivo, partnering, SHP2
0 Comment
News/ News/ News/ Oncology/ R&D
Roche’s TIGIT ambitions take another blow
Phil Taylor
immuno-oncology, Non-small cell lung cancer, Oncology, Roche, TIGIT, tiragolumab
0 Comment
Digital/ News/ News/ News/ Oncology
Roche extends Kaiku digital monitoring partnership again
Phil Taylor
digital, digital health, Kaiku Health, partnering, patient monitoring, Roche
0 Comment
News/ News/ News/ Oncology/ R&D
Nykode vaccine shows its worth in cervical cancer trial
Phil Taylor
cancer vaccine, cervical cancer, HPV, immuno-oncology, Nykode Therapeutics, Oncology, Vaccibody
0 Comment
Digital/ News/ News/ News/ News/ Oncology/ Patients
Game used to track symptoms in children with cancer
Phil Taylor
digital, digital health, games for health, Oncology, paediatrics, patients
0 Comment
News/ News/ News/ Oncology/ Sales and Marketing
Manufacturing foul-up hits Novartis’ radioligand business
Phil Taylor
Lutathera, manufacturing, Novartis, Oncology, Pluvicto, Radiopharmaceutical
0 Comment
Market Access/ News/ News/ News/ Oncology
AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer
Phil Taylor
AstraZeneca, biliary tract cancer, Imfinzi, immuno-oncology, Oncology
0 Comment
Market Access/ News/ News/ News/ Oncology
Kymriah is first CAR-T cleared for follicular lymphoma in EU
Phil Taylor
CAR-T therapies, cell therapy, Gilead Sciences, immuno-oncology, Kymriah, Novartis, Oncology, regulatory approval, Yescarta
0 Comment